genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
Psoriatic arthritis
News
Janssen, Isis Pharma Ink Up-to-$835M Antisense Agreement
News
Sun Pharma Licenses Merck & Co. Phase III Psoriasis Candidate in $80M+ Accord
Drug Discovery
UCB, Dermira to Repurpose Arthritis Drug to Treat Psoriasis
Drug Discovery
Baxter, Coherus Ink Biosimilar Collaboration Worth Up to $246M
Drug Discovery
Firms Partner on Bispecific Fynomer Therapeutics
News
Abbott Expects Spinoff AbbVie to Be a $17.4B Proprietary Drug-CMO Powerhouse
News
Janssen’s Stelara Improves Active Psoriatic Arthritis in Phase III Study
News
Late-Stage Study Shows Benefits of Abbott’s Humira Against Nonradiographic axSpA
Drug Discovery
Merck & Co. Teams with Hanwha to Develop Biosimilar Enbrel
Industry News
BMS to Shell Out $2.4B for Medarex
1
2
3
Page 2 of 3
Scroll Up